论文部分内容阅读
该文旨在比较局部注射皮质类固醇激素(IC)和口服普萘洛尔治疗眶周血管瘤(IH)的疗效。对确诊为IH的29例患儿采取IC治疗,14例患儿采用普萘洛尔治疗。整个治疗过程直到病变没有改善为止,对治疗结果进行评价。通过对治疗开始和结束的目测结果,记录肿瘤类型、治疗时间、并发症及辅助治疗并评分。结果,接受IC治疗的29例患者中,21(72%)例接受第二个疗程的注射治疗,16(55%)例接受超过2个疗程的治疗。IC治疗的平均时间为15.9个月,普萘洛尔治疗的平均时间为6.5个月(P<0.001)。IC治疗组中,9例出现肿瘤破溃出血,7例发生溃疡。普萘洛尔组未见明显并发症。IC组中1例
The aim of this study was to compare the efficacy of topical corticosteroids (ICs) and propranolol in the treatment of periorbital hemangiomas (IH). 29 children diagnosed with IH were treated with IC and 14 with propranolol. The entire course of treatment until the lesions did not improve so far, the treatment results were evaluated. Tumor type, treatment time, complications and adjuvant therapy were recorded and scored by visual inspection of the beginning and end of treatment. As a result, 21 (72%) of 29 patients receiving IC received a second course of injection and 16 (55%) received more than 2 courses of treatment. The mean duration of IC therapy was 15.9 months, with propranolol 6.5 months (p <0.001). IC treatment group, 9 cases of tumor rupture bleeding, ulcers in 7 cases. Propranolol group no significant complications. 1 in IC group